Call Today   (800)201-6475 Free consultation. 24 hour help-line

Tell Us About Your Injury

Please select any SGLT2 inhibitors you took during or after May 2013:

Were you diagnosed with Fournier’s Gangrene by a medical professional?

Were you subject to any amputations due to side effects linked to the consumption of these drugs?

Did Symptoms begin during use or within 90 days of last ingestion?

Please describe any additional side effects you have experienced

Accepting Cases
> Lawsuits > SGLT2

Did you take an SGLT2 Inhibitor Drug and were diagnosed with Fournier’s Gangrene?

You may be entitled to compensation. Finding out if you are eligible for a large settlement for these issues is 100% FREE, fast and easy

  • The FDA has identified 12 cases of Fournier's gangrene in patients taking an SGLT2 inhibitor
  • One of the cases resulted in the death of a patient
  • An estimated 1.7 million patients were prescribed an SGLT2 inhibitor during 2017 alone

Reported Side Effects of SGLT2 Inhibitors:

  • Necrotizing Fasciitis of the Perineumn (also referred to as Fournier’s Gangrene)
  • Genital yeast infections in men and women
  • Kidney problems
  • Constipation
  • Urinary discomfort
  • Nasal congestion
  • Flu like symptoms
  • Increased urination
  • Urinary tract infections (UTIs)
  • Serious allergic reactions
  • Kidney failure
  • Hypotension (low blood pressure)
  • Increased cholesterol levels
  • Increased bladder cancer risk
  • Ketoacidosis
  • Liver Damage
  • Hyperkalemia (high levels of potassium in the blood)
  • Back pain
  • Dehydration
  • Hypoglycemia (when combined with insulin or drugs that increase insulin production)

Regulatory History

May 2015 Many reports of ketoacidosis and diabetic ketoacidosis (DKA) requiring hospitalization

September 2015 Label update warning about increased risk of bone fracture

December 2015 Label change for SGLT2 inhibitors about increased risk of ketoacidosis and serious urinary tract infections

May 2016 First amputation warning based on interim analysis of CANVAS and CANVAS-R studies

June 2016 Communication to doctors with stronger warnings about kidney injury risks

May 2017 Second amputation warning, requiring a label update with a boxed warning

August 2018 Invokana and other SGLT2 inhibitors may lead to a flesh-eating genital infection (Fournier’s gangrene or necrotizing fasciitis)